The next generation of non-invasive prenatal screening.

Using a simple blood draw from the mother, Panorama™ provides >99% combined accuracy for trisomies 13, 18, and 21, fetal sex and triploidy.  A microdeletion panel (including 22q11.2 deletion syndrome) is also available to provide unparalleled scope and reliability among non-invasive prenatal screens.


Expecting Parents
Learn More

Healthcare Providers
Learn More


Not all prenatal screens are created equal.  Click here to compare Panorama™ to other testing options. 



Clinical experience and follow-up with large scale single-nucleotide polymorphismebased noninvasive prenatal aneuploidy testing. Click here to read Panorama's clinical performance was consistent with performance in validation studies. by Pe'er Dar, MD et al.

Panorama successfully identified vanished twin, previously unrecognized twin, and triploid pregnancies. Click here to read Detection of triploid, molar, and vanishing-twin pregnancies by a single-nucleotide polymorphism-based non-invasive prenatal test by Kristen Curnow, Ph.D.